Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18486739 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
Condition: Psoriasis
Interventions: Drug: ustekinumab;   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.